Hi Esmer
By choosing when to finish recruiting for each monotherapy trial (DEP Cabaz and DEP docetaxel), it will have been easy for them to engineer the finishing of those two trials around the same time. Thereby sending the numbers to the number-crunchers around the same time. This would result in getting the top-line results around the same time / in close succession.
Choosing a data cut-off point for the DEP irinotecan trial and sending that data to the number crunchers at a chosen time could result in an interim read-out for the DEP irinotecan trial at a roughly pre-determined time as well, if the company wishes to do that.
So, it would easily engineered, without breaking any rules, for readouts to come out fairly close together.
Cheers
Gumnut
Optimism, page-36
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $41.31M | |||
| Open | High | Low | Value | Volume |
| 10.0¢ | 10.0¢ | 9.9¢ | $14.97K | 151.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 372123 | 9.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.0¢ | 5042 | 1 |
View Market Depth
| Last trade - 16.10pm 27/09/2024 (20 minute delay) ? |
| SPL (ASX) Chart |